BiomX
NESS ZIONA, L3, Israel · Biotechnology, Healthcare, Health Care · 20 employees
BiomX is focused on acquiring and developing technologies that identify, analyze, protect against, and support faster responses to physical threats. The company operates as a subsidiary of BiomX Inc. and is involved in enhancing security systems. With a strategic focus on defense and security, BiomX aims to integrate advanced technologies into operational environments. It addresses critical infras
Funding history
- Venture - Series Unknown — $3.3M — Jan 2026
- Venture - Series Unknown — $61.5M — Apr 2024
- Seed — $1.5M — Mar 2023
- Seed — $3.0M — Jan 2022
- Venture - Series Unknown — $3.0M — Oct 2021
Recent signals
- Jul 28, 2026: BiomX amends acquisition terms for Zorronet
- Jul 08, 2026: BiomX to acquire 60% of Tsoock for $10.4 million
- Apr 10, 2026: BiomX acquires Zorronet for defense tech expansion
- Mar 11, 2026: SEC 8-K (5.07): On March 11, 2026, BiomX Inc. held a special meeting of stockholders, which was originally scheduled for February 25, 2026, but was adjourned to allow additional time for stockholder votes. As of the record date, February 3, 2026, there were 1,593,516 shares of common stock outstanding, all of which were eligible to vote at the meeting. The special meeting achieved quorum with all shares present either in person or by proxy, and no broker non-votes were recorded. The outcome of the proposals will impact the governance of the company and strategic decision-making moving forward.
- Mar 09, 2026: BiomX Appoints Michael Oster as Chief Executive Officer and David Rokach as Chief Financial Officer
- Jan 20, 2026: Raised $3.3M in Venture - Series Unknown
- Feb 26, 2025: BiomX Announces Financing of $12 Million to Advance BX004 Program in Cystic Fibrosis Patients
- Apr 01, 2024: Raised $61.5M in Venture - Series Unknown
See plans & pricing → Track BiomX’s funding, hiring, and signals — with verified contacts — on Fundz.